CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Common Class A [Member]	Common Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at beginning at Dec. 31, 2017		$ 144	$ 24,856	$ (1,558)	$ 23,442
Balance at beginning (in shares) at Dec. 31, 2017		1,437,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of 5,750,000 Units, net of underwriting discounts and offering expenses	$ 575		55,651,147		$ 55,651,722
Sale of 5,750,000 Units, net of underwriting discounts and offering expenses (in shares)	5,750,000				5,750,000
Sale of 243,750 Founder Units	$ 24		2,437,476		$ 2,437,500
Sale of 243,750 Founder Units (in shares)	243,750				243,750
Sale of Unit Purchase Option			100		$ 100
Common stock subject to possible redemption	$ (530)		(53,101,009)		(53,101,539)
Common stock subject to possible redemption (in shares)	(5,304,398)
Net income (loss)				(11,224)	(11,224)
Balance at end at Mar. 31, 2018	$ 69	$ 144	5,012,570	(12,782)	5,000,001
Balance at end (in shares) at Mar. 31, 2018	689,352	1,437,500
Balance at beginning at Dec. 31, 2017		$ 144	24,856	(1,558)	$ 23,442
Balance at beginning (in shares) at Dec. 31, 2017		1,437,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock subject to possible redemption (in shares)					(5,234,134)
Balance at end at Dec. 31, 2018	$ 76	$ 144	5,031,298	(31,515)	$ 5,000,003
Balance at end (in shares) at Dec. 31, 2018	759,616	1,437,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of 243,750 Founder Units
Sale of Unit Purchase Option
Common stock subject to possible redemption	$ 2		(86,378)		(86,376)
Common stock subject to possible redemption (in shares)	(17,057)
Net income (loss)				86,378	86,378
Balance at end at Mar. 31, 2019	$ 78	$ 144	$ 4,944,920	$ 54,863	$ 5,000,005
Balance at end (in shares) at Mar. 31, 2019	776,673	1,437,500